Evidence map›Paper›PMID 40038141›Full record

ArticleEuropean journal of epidemiology2025

Two-step pragmatic subgroup discovery for heterogeneous treatment effects analyses: perspectives toward enhanced interpretability.

Toshiaki Komura, Falco J Bargagli-Stoffi, Koichiro Shiba, Kosuke Inoue

Abstract read
In one paragraph

Article in European journal of epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Toshiaki KomuraDepartment of Social and Behavioral Sciences, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Falco J Bargagli-StoffiDepartment of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, USA.
Koichiro ShibaDepartment of Epidemiology, School of Public Health, Boston University, Boston, MA, USA.
Kosuke InoueDepartment of Social Epidemiology, Graduate School of Medicine, Kyoto University, Floor 2, Science Frontier Laboratory, Yoshida-konoe-cho, Sakyo-ku, Kyoto, 604-8146, Japan. inoue.kosuke.2j@kyoto-u.ac.jp.ORCID http://orcid.org/0000-0001-9614-8103

Funding

Japan Agency for Medical Research and Development JP22rea522107Japan Science and Technology Agency JPMJPR23R2Japan Society for the Promotion of Science 22K17392Japan Society for the Promotion of Science 23KK0240Program for the Development of Next-generation Leading Scientists with Global Insight Program for the Development of Next-generation Leading Scientists with Global Insight
6 · The paper itself

Abstract

Effect heterogeneity analyses using causal machine learning algorithms have gained popularity in recent years. However, the interpretation of estimated individualized effects requires caution because insights from these data-driven approaches might be misaligned with the contextual needs of a human audience. Thus, a practical framework that integrates advanced machine learning methods and decision-making remains critically needed to achieve effective implementation and scientific communication. We introduce a 2-step framework to identify characteristics associated with substantial effect heterogeneity in a practically relevant format. The proposed framework applies distinct sets of covariates for (i) estimation of individualized effects and (ii) subgroup discovery and shows the subgroups with heterogeneity based on highly interpretable if-then rules. By referring to existing metrics of interpretability, we describe how each step contributes to leveraging a theoretical advantage of machine learning models while creating an interpretable and practically relevant framework. We applied the pragmatic subgroup discovery framework for the Look AHEAD (Action for Health in Diabetes) trial to assess practically relevant and comprehensive insights into the effect heterogeneities of intense lifestyle intervention for individuals with diabetes on cardiovascular mortality. Our analysis identified (i) individuals with history of cardiovascular disease and myocardial infarction had the least benefit from the intervention, while (ii) individuals with no history of cardiovascular diseases and HbA1c < 7% received the highest benefit. In summary, our practical framework for heterogeneous effects discovery could be a generic strategy to ensure both effective implementation and scientific communication when applying machine learning algorithms in epidemiological research.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2Machine LearningAlgorithmsHumansLife StyleTreatment Effect HeterogeneityCardiovascular eventsCausal machine learningDiabetesHeterogeneous treatment effectScientific communication

Identifiers

PMID40038141
PMCPMC12018488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.